Written by Cris Franco Why are so many of the neuro-diverse community drawn to the arts? Perhaps it’s because their unique ...

President Bola Tinubu has approved the reappointment of Dr Afis Agboola as the Provost and Medical Director of the Federal ...

Ultragenyx Pharmaceutical (RARE) shows promising results for GTX-102 in Angelman syndrome Phase 1/2 trial, supporting a Phase ...

Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Erin Wright, M.D., is the new chairholder of the Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and ...

Finding the right remedy can feel daunting in a world increasingly dominated by stress and sleepless nights. Sleep is a vital component of our overall health, affecting everything from mood and ...

Lake Street raised the firm’s price target on ClearPoint Neuro (CLPT) to $17 from $15 and keeps a Buy rating on the shares. Q3 outperformance was driven by another quarter of broad-business strength, ...

The device is designed to detect hemorrhage in specific regions of the brain and provide rapid diagnosis of traumatic brain ...

Reports Q3 revenue $22.0M, consensus $25.3M. Jim Green, Chairman and CEO, said, “Our third quarter revenues continued to reflect the ...

Michael Platten is the winner of the “Breakthrough of the Year 2024” in the Life Sciences category of the Falling Walls Foundation.

We're all chasing the dream of a better work-life balance in a calmer environment, and some cities are attuned to easing your ...

In October, Archimed bought FIM Medical, in its latest acquisition. The company provides vision, hearing and respiratory care ...